Zimmer Partners’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.78M | Sell |
180,100
-121,300
| -40% | -$5.24M | 0.17% | 84 |
|
|
2025
Q1 | $10.4M | Buy |
301,400
+121,000
| +67% | +$4.18M | 0.2% | 72 |
|
|
2024
Q4 | $4.95M | Buy |
+180,400
| New | +$4.95M | 0.09% | 102 |
|
|
2024
Q2 | – | Sell |
-73,200
| Closed | -$2.26M | – | 153 |
|
|
2024
Q1 | $2.26M | Buy |
73,200
+8,200
| +13% | +$254K | 0.05% | 108 |
|
|
2023
Q4 | $2.62M | Sell |
65,000
-10,000
| -13% | -$404K | 0.1% | 79 |
|
|
2023
Q3 | $1.98M | Buy |
+75,000
| New | +$1.98M | 0.05% | 96 |
|
|
2020
Q1 | – | Sell |
-17,000
| Closed | -$596K | – | 76 |
|
|
2019
Q4 | $596K | Hold |
17,000
| – | – | 0.01% | 78 |
|
|
2019
Q3 | $365K | Hold |
17,000
| – | – | ﹤0.01% | 101 |
|
|
2019
Q2 | $458K | Buy |
+17,000
| New | +$458K | ﹤0.01% | 99 |
|